U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07463404) titled 'Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement' on March 05.
Brief Summary: Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement
Study Start Date: Dec. 01, 2023
Study Type: INTERVENTIONAL
Condition:
Temporomandibular Joint Internal Derangement
Intervention:
COMBINATION_PRODUCT: Inject Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor after arthrocentesis...